Lv42
650 积分 2024-10-16 加入
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA
6天前
已完结
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
28天前
已完结
A comprehensive map of molecular drug targets
1个月前
已完结
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
1个月前
已完结
RETRACTED ARTICLE: Pericyte degeneration causes white matter dysfunction in the mouse central nervous system
1个月前
已完结
Structural Features of the Kinase Domain
1个月前
已完结
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
1个月前
已完结
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
1个月前
已完结
Pharmacogenomics: will the promise be fulfilled?
2个月前
已完结
Big data in basic and translational cancer research
2个月前
已完结
皖公网安备34019202002308
